Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- 1) Biomechanical construct comparison between FiberTak DR Bridge and SpeedBridge 2)Anchor insert No ClinicalTrials.gov identifier reported
- 1) Biomechanical construct comparison between FiberTak DR Bridge and SpeedBridge 2)Anchor insert No ClinicalTrials.gov identifier reported
- 1B: Study #3033-2; Incidence and Predictors of Opioid Overdose and Death among ER/LA Opioid Analgesics Users as Measured by Diagnoses and Death Records A Retrospective Database Study No ClinicalTrials.gov identifier reported
- 1-Day Dispensing Evaluation of Nesofilcon A Lenses With Alternate Packaging Solutions No ClinicalTrials.gov identifier reported
- 1-Fa7759 No ClinicalTrials.gov identifier reported
- 1) Fetal Heart Function in Normal and Complicated Pregnancies 2)Myocardial Deformation and Ventricular Mechanics in Fetuses With Twin-Twin Transfusion Before and After Fetoscopic Laser Photocoagulation No ClinicalTrials.gov identifier reported
- 1L Biliary Tract Cancer No ClinicalTrials.gov identifier reported
- 1 level prodisc Nova, SK and Vivo PMA supplement - Cadaver study -evaluation of 4 different cervical TDR prosthesis No ClinicalTrials.gov identifier reported
- 1Lm SCLC Tecentriq Lurbinectedin No ClinicalTrials.gov identifier reported
- 1L Mtnbc Ipatasertib Tecentriq Paclitaxel No ClinicalTrials.gov identifier reported
- 1L Nsclc DX All Comer Non Squamous No ClinicalTrials.gov identifier reported
- 1L Nsclc DX All Comer Squamous No ClinicalTrials.gov identifier reported
- 1L Nsclc Non Squamous DX All Comer Abraxane No ClinicalTrials.gov identifier reported
- 1L-Oa-Dlbcl No ClinicalTrials.gov identifier reported
- 1L SCLC Ed No ClinicalTrials.gov identifier reported
- 1Nspire Study: Investigating 1L Maintenance Niraparib Safety and Patie No ClinicalTrials.gov identifier reported
- 1Nspire Study: Investigating 1L Maintenance Niraparib Safety and Patie No ClinicalTrials.gov identifier reported
- 1-Q3ras No ClinicalTrials.gov identifier reported
- 1Qtr22 Clp-20 Discover-US No ClinicalTrials.gov identifier reported
- 1Qtr22 Clp-21 No ClinicalTrials.gov identifier reported
- 1Qtr22 Clp-21 Acqforce Flutter Ide No ClinicalTrials.gov identifier reported
- 1 Restriction Spectrum Imaging in the Breast: Diagnosis and Treatment Monitoring 2 Rsi-Mri As A Biomarker for Therapy Response in Primary and Metastatic Prostate Cancer No ClinicalTrials.gov identifier reported
- 1st Line CRC No ClinicalTrials.gov identifier reported
- 1st Line (MRD)P2 study to evaluate Blincyto in Front line MRD+ patients No ClinicalTrials.gov identifier reported
- 1st Line (MRD)P2 study to evaluate Blincyto in Front line MRD+ patients. No ClinicalTrials.gov identifier reported
- 1st Line P2 study to evaluate Blincyto in combination with R-Chemo in subjects with high risk DLB No ClinicalTrials.gov identifier reported
- 1st metatarsal phalangeal joint fusion with nitinol staples No ClinicalTrials.gov identifier reported
- 1st replapse after len-containing regimen No ClinicalTrials.gov identifier reported
- (1) Study of the FLASH Proton Therapy Effect on The Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma No ClinicalTrials.gov identifier reported
- 1Vit14039 NCT02453334
- 1Vit14039 No ClinicalTrials.gov identifier reported
- 1Vit15042 No ClinicalTrials.gov identifier reported
- 1Vit15042 NCT02826681
- 1Vit15043 NCT03037931
- 1Vit15043 No ClinicalTrials.gov identifier reported
- 1Vit17044 No ClinicalTrials.gov identifier reported
- 1Vit17044 NCT03523117
- 1Vit18045 NCT04269707
- 1Vit18045 No ClinicalTrials.gov identifier reported
- 1Vit19046 No ClinicalTrials.gov identifier reported
- 1Vit22048 No ClinicalTrials.gov identifier reported
- 1- Week Dispensing Evaluation of Crystal Ke Lenses With A Novel Contact Lens Packaging Solution Ups04 Compared to Crystal Ke Lenses With Prs03 Packaging Solution No ClinicalTrials.gov identifier reported
- 1- Week Dispensing Evaluation of kalifilcon A Lenses with 0.02 PEG Modified Hyaluronic Acid Packaging Solution Compared to kalifilcon A Lenses with UPS04 Packaging Solution No ClinicalTrials.gov identifier reported
- 1- Week Dispensing Evaluation of kalifilcon A Lenses with 0.02% PEG Modified Hyaluronic Acid Packaging Solution Compared to kalifilcon A Lenses with UPS04 Packaging Solution No ClinicalTrials.gov identifier reported
- 1-Week Dispensing Evaluation of Naturalvue Multifocal 1 Day Contact Lenses Compared to Ultra for Presbyopia Contact Lenses No ClinicalTrials.gov identifier reported
- 1- Week Dispensing Evaluation of Nesofilcon A Contact Lenses With A Novel Contact Lens Packaging Solution Ups04 VS. Commercially Available BL Biotrue Oneday No ClinicalTrials.gov identifier reported
- 1- Week Dispensing Evaluation of samfilcon A Lenses with Positive Spherical Aberration Compared to Biofinity Energys Lenses No ClinicalTrials.gov identifier reported
- 1 year outcomes of Vivity IOL versus Control No ClinicalTrials.gov identifier reported
- 20-000917 Reapplix 3C Patch System for the Treatment of Diabetic Foot Ulcers A Medicare Claims Study No ClinicalTrials.gov identifier reported
- 200058 No ClinicalTrials.gov identifier reported